Anti-Virulence Therapy

Advertisement

cGxPJobs Banner

Infex Therapeutics Advances RESP-X Phase IIa Data at ERS 2026

Alderley Park, Cheshire, U.K., August 19, 2026 Infex Therapeutics will present new Phase IIa data for RESP-X (INFEX702) in...

By cGxPwire Editor
August 20, 2026

Read More

Advertisement

cGxPJobs

Directory